Reuters : health
1
South Korea urges public to stop using liquid e-cigarettes  02h26 23 octobre
South Korea’s health minister said on Wednesday he strongly advised the public to stop using liquid e-cigarettes amid a global backlash against vaping over growing health concerns.
2
Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell  01h49 23 octobre
Facing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby Powder, the company’s Chief Executive Alex Gorsky earlier this month insisted that the company’s iconic brand was safe.
3
Women giving birth in low-income countries often endure abuse  21h09 22 octobre
Reuters Health) - Women are often mistreated during labor and delivery at hospitals in low-income countries, a new study suggests.
4
Biogen resurrects Alzheimer’s drug; shares jump 27%  21h08 22 octobre
Biogen Inc revived plans on Tuesday to seek U.S. approval for Alzheimer’s treatment aducanumab, surprising investors and saying data from more patients in two discontinued studies showed the drug reduced the decline of patients suffering from the disease.
5
More than 100 elephants die in Botswana in suspected anthrax outbreak  19h26 22 octobre
More than 100 elephants have died in Botswana in the past two months partly because of a suspected anthrax outbreak, the government said on Tuesday.
6
Bulimia tied to higher risk of heart disease and premature death  19h18 22 octobre
Reuters Health) - Women hospitalized for bulimia may be more likely to develop heart disease and die prematurely, a recent study suggests.
7
Canadian election clears path for universal drug plan  19h13 22 octobre
Canada’s Liberal government is more likely to pass a universal prescription drug plan after losing its majority in Monday’s election, setting the stage for what would be the biggest shakeup of the country’s public healthcare system since it was created in the 1960s.
8
Most preemies are healthy in adulthood  18h31 22 octobre
Reuters Health) - More than half of premature infants grow up to be healthy adults without chronic medical issues, a new study suggests.
9
Novartis data suggest payers getting breaks on gene therapy Zolgensma  14h50 22 octobre
Novartis sales data on Tuesday suggested the Swiss drugmaker is reaping less than the 2.1 million U.S. list price for its gene therapy Zolgensma, as insurers may be getting breaks on the world’s most-expensive one-time treatment.
10
Idorsia’s Clozel says recruitment delay won’t dent Fabry drug prospects  14h29 22 octobre
Fledgling Swiss biotech Idorsia has suffered delays in recruiting patients for a key trial of its experimental lucerastat drug but that will not damage its commercial prospects, founder Jean-Paul Clozel told Reuters on Tuesday.
11
Kenya launches first breast milk bank to help newborns  13h29 22 octobre
The five mothers sat in a bright blue room in Kenya’s largest maternity hospital waiting to pump breast milk - but not for their own newborns.
12
Climate change hampers progress on fighting epidemics: Global Fund  13h26 22 octobre
Climate change is making it harder to eradicate deadly epidemics, with rising temperatures helping mosquitoes spread malaria in higher places in Africa, the head of a global health fund said on Tuesday.
13
Trump administration says Obamacare plan premiums to fall  13h08 22 octobre
Monthly premiums for an average 2020 Obamacare health insurance plan will fall about 4 percent from this year, according to a report released Tuesday by the Trump administration, which has tried to dismantle the program.
14
Bristol-Myers’ immunotherapies show promise in lung cancer trial; shares rise  13h05 22 octobre
Bristol-Myers Squibb Co said on Tuesday an interim analysis of a late-stage trial testing a combination of its immuno-oncology drugs Opdivo and Yervoy met the main goal of extending life of previously untreated lung cancer patients.
15
HIV-positive British living in Spain could lose healthcare post-Brexit  10h19 22 octobre
Reuters Health) - British citizens with HIV who live in Spain could face serious healthcare challenges in the event of a no-deal Brexit, potentially risking public health at large, researchers say.